Inhye Ahn
Academic / Other · 3 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Mosunetuzumab for CLL MRD Clearance Leukemia, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma | Phase 1 / Phase 2 | 2025-11-24 |
| Recruiting | Fixed Duration Pirtobrutinib and Obinutuzumab in Chronic Lymphocytic Leukemia Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma | Phase 2 | 2024-04-22 |
| Withdrawn | Copanlisib Plus Ibrutinib or Acalabrutinib in R/R CLL Chronic Lymphocytic Leukemia (CLL) | Phase 2 | 2021-02-18 |